The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Assessment of ocular transduction using single-stranded and self-complementary recombinant adeno-associated virus serotype 2/8
Abstract
To date adeno-associated viral (AAV) vectors are the only gene therapy vectors that have been shown to efficiently transduce photoreceptor cells and have thus become the most commonly used vector for ocular transduction. Various AAV serotypes have been evaluated in the eye, the first of which was AAV2, which is able to transduce photoreceptors, retinal pigment epithelium (RPE) and retinal ganglion cells. AAV serotypes 1 and 4, as well as AAV2 pseudotyped with these capsids, only transduce the RPE. AAV serotype 5 and AAV2/5 transduce the photoreceptors as well as RPE, but not retinal ganglion cells. Here, we assessed the capacity of the novel serotype AAV2/8 to transduce various ocular tissues of the adult murine retina by administering AAV2/8 green fluorescent protein intravitreally, subretinally and intracamerally. We also determined the kinetics and efficiency of self-complementary AAV (scAAV) vectors of serotypes 2/2, 2/5 and 2/8 and compared them with single-stranded AAV (ssAAV). We found that ssAAV2/8 transduces photoreceptors and RPE more efficiently than ssAAV2/2 and ssAAV2/5, and that scAAV2/8 had faster onset and higher transgene expression than ssAAV2/8. This improved transduction efficiency might facilitate the development of improved gene therapy protocols for inherited retinal degenerations, particularly those caused by defects in photoreceptor-specific genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the use of AAV8, a serotype known to reach a transduction plateau only after 7 weeks (11).”
From Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models (2025) · cites this paper as [11]
In the citing paper
“AAV8 is highly effective in transducing photoreceptors (PRs) and the retinal pigmented epithelium (RPE) as compared to AAV2 and AAV5 in mice [69].”
From The Ocular Gene Delivery Landscape (2021) · cites this paper as [69]
Citations
Cites
Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy
Gao, G.-P., Alvira, M. R., Wang, L., Calcedo, R., Johnston, J., & Wilson, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182412299 · Cited by 1,520
Gene therapy restores vision in a canine model of childhood blindness
Acland, G. M., Aguirre, G. D., Ray, J., Zhang, Q., Aleman, T. S., Cideciyan, A. V., Pearce-Kelling, S. E., Anand, V., Zeng, Y., Maguire, A. M., et al. (2001) · Nature Genetics · doi:10.1038/ng0501-92 · Cited by 1,202
Inagaki, K., Fuess, S., Storm, T. A., Gibson, G. A., Mctiernan, C. F., Kay, M. A., & Nakai, H. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.03.014 · Cited by 610
Nathwani, A. C., Gray, J. T., Ng, C. Y. C., Zhou, J., Spence, Y., Waddington, S. N., Tuddenham, E. G. D., Kemball-Cook, G., McIntosh, J., Boon-Spijker, M., et al. (2006) · Blood · doi:10.1182/blood-2005-10-4035 · Cited by 421
Self-citationAuricchio, A. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.26.3075 · Cited by 403
Wang, Z., Ma, H.-I., Li, J., Sun, L., Zhang, J., & Xiao, X. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302133 · Cited by 367
Thomas, C. E., Storm, T. A., Huang, Z., & Kay, M. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.6.3110-3122.2004 · Cited by 358
Clark, K. R., Liu, X., Mcgrath, J. P., & Johnson, P. R. (1999) · Human Gene Therapy · doi:10.1089/10430349950018427 · Cited by 305
Ali, R. R., Sarra, G.-M., Stephens, C., Alwis, M. D., Bainbridge, J. W. B., Munro, P. M., Fauser, S., Reichel, M. B., Kinnon, C., Hunt, D. M., et al. (2000) · Nature Genetics · doi:10.1038/77068 · Cited by 304
Self-citationAuricchio, A., Hildinger, M., O'Connor, E., Gao, G.-P., & Wilson, J. M. (2001) · Human Gene Therapy · doi:10.1089/104303401450988 · Cited by 297
Adeno-associated virus: from defective virus to effective vector
Gonçalves, M. A. (2005) · Virology Journal · doi:10.1186/1743-422x-2-43 · Cited by 264
Gene transfer into the mouse retina mediated by an adeno-associated viral vector
Ali, R. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.5.591 · Cited by 255
Self-citationIntracellular trafficking of adeno-associated viral vectors
Ding, W., Zhang, L., Yan, Z., & Engelhardt, J. F. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302527 · Cited by 251
Novel adeno-associated virus serotypes efficiently transduce murine photoreceptors
Allocca, M., Mussolino, C., Garcia-Hoyos, M., Sanges, D., Iodice, C., Petrillo, M., Vandenberghe, L. H., Wilson, J. M., Marigo, V., Surace, E. M., et al. (2007) · Journal of Virology · doi:10.1128/jvi.01327-07 · Cited by 246
Davidoff, A. M., Gray, J. T., Ng, C. Y. C., Zhang, Y., Zhou, J., Spence, Y., Bakar, Y., & Nathwani, A. C. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.12.022 · Cited by 218
Self-citationReal-time, noninvasive in vivo assessment of adeno-associated virus-mediated retinal transduction.
Bennett, J., Duan, D., Engelhardt, J. F., & Maguire, A. M. (1997) · PubMed · Cited by 204
Yang, G. S., Schmidt, M., Yan, Z., Lindbloom, J. D., Harding, T. C., Donahue, B. A., Engelhardt, J. F., Kotin, R., & Davidson, B. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.15.7651-7660.2002 · Cited by 204
Weber, M., Rabinowitz, J., Provost, N., Conrath, H., Folliot, S., Briot, D., Chérel, Y., Chenuaud, P., Samulski, J., Moullier, P., et al. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00098-4 · Cited by 203
Broekman, M. L. D., Comer, L. A., Hyman, B. T., & Sena-Esteves, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2005.11.057 · Cited by 200
Gene therapy progress and prospects: the eye
Bainbridge, J. W., Tan, M. H., & Ali, R. R. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302812 · Cited by 162
Self-citationPersistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV
Dudus, L., Anand, V., Acland, G. M., Chen, S.-J., Wilson, J. M., Fisher, K. J., Maguire, A. M., & Bennett, J. (1999) · Vision Research · doi:10.1016/s0042-6989(98)00308-3 · Cited by 160
AAV-Mediated gene transfer slows photoreceptor loss in the RCS rat model of retinitis pigmentosa
Smith, A. J., Schlichtenbrede, F. C., Tschernutter, M., Bainbridge, J. W., Thrasher, A. J., & Ali, R. R. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00144-8 · Cited by 147
Self-citationDavidoff, A. M., Ng, C. Y., Sleep, S., Gray, J. T., Azam, S. A., Zhao, Y., McIntosh, J., Karimipoor, M., & Nathwani, A. C. (2004) · Journal of Virological Methods · doi:10.1016/j.jviromet.2004.07.001 · Cited by 135
Self-citationWang, Z., Zhu, T., Rehman, K. K., Bertera, S., Zhang, J., Chen, C., Papworth, G. D., Watkins, S. C., Trucco, M., Robbins, P. D., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-0927 · Cited by 132
Structure of Adeno-Associated Virus Vector DNA following Transduction of the Skeletal Muscle
Vincent, N., Snyder, R. O., Gluzman, R., Bohl, D., Lagarde, C., & Danos, O. (1999) · Journal of Virology · doi:10.1128/jvi.73.3.1949-1955.1999 · Cited by 115
Major role of local immune responses in antibody formation to factor IX in AAV gene transfer
Wang, L., Cao, O., Swalm, B., Dobrzynski, E., Mingozzi, F., & Herzog, R. W. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302539 · Cited by 98
Akache, B., Grimm, D., Shen, X., Fuess, S., Yant, S. R., Glazer, D. S., Park, J., & Kay, M. A. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300053 · Cited by 98
Buch, P. K., MacLaren, R. E., Durán, Y., Balaggan, K. S., MacNeil, A., Schlichtenbrede, F. C., Smith, A. J., & Ali, R. R. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.05.019 · Cited by 96
Self-citationSchlichtenbrede, F. C., da Cruz, L., Stephens, C., Smith, A. J., Georgiadis, A., Thrasher, A. J., Bainbridge, J. W., Seeliger, M. W., & Ali, R. R. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.401 · Cited by 87
Self-citationEvaluation of recombinant adeno-associated virus as a gene transfer vector for the retina
Grant, C. A., Ponnazhagan, S., Wang, X.-S., Srivastava, A., & Li, T. (1997) · Current Eye Research · doi:10.1076/ceyr.16.9.949.5046 · Cited by 86
Sarra, G., Stephens, C., Schlichtenbrede, F. C., Bainbridge, J. W., Thrasher, A. J., Luthert, P. J., & Ali, R. R. (2002) · Vision Research · doi:10.1016/s0042-6989(01)00230-9 · Cited by 61
Self-citationRolling, F., Shen, W.-Y., Tabarias, H. A., Constable, I. J., Kanagasingam, Y., Barry, C. J., & Rakoczy, P. E. (1999) · Human Gene Therapy · doi:10.1089/10430349950018715 · Cited by 60
Broderick, C. A., Smith, A. J., Balaggan, K. S., Georgiadis, A., Buch, P. K., Trittibach, P. C., Barker, S. E., Sarra, G., Thrasher, A. J., Dick, A. D., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.03.018 · Cited by 59
Self-citationPseudotyped AAV vectors for constitutive and regulated gene expression in the eye
Auricchio, A. (2003) · Vision Research · doi:10.1016/s0042-6989(02)00676-4 · Cited by 57
Zhang, X., de Alwis, M., Hart, S. L., Fitzke, F. W., Inglis, S. C., Boursnell, M. E. G., Levinsky, R. J., Kinnon, C., Ali, R. R., & Thrasher, A. J. (1999) · Human Gene Therapy · doi:10.1089/10430349950016861 · Cited by 47
Self-citationRen, C., Kumar, S., Shaw, D. R., & Ponnazhagan, S. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.1047 · Cited by 36
Ali, R. R. (2003) · Novartis Foundation symposium · doi:10.1002/0470092645.ch12 · Cited by 25
Self-citationLai, Y. K. Y., Rolling, F., Baker, E., & Rakoczy, P. E. (2001) · Experimental Cell Research · doi:10.1006/excr.2001.5236 · Cited by 9
Cited by
Self-complementary AAV vectors; advances and applications
McCarty, D. M. (2008) · Molecular Therapy · doi:10.1038/mt.2008.171 · Cited by 515
High-efficiency transduction of the mouse retina by tyrosine-mutant AAV serotype vectors
Petrs-Silva, H., Dinculescu, A., Li, Q., Min, S.-H., Chiodo, V., Pang, J.-J., Zhong, L., Zolotukhin, S., Srivastava, A., Lewin, A. S., et al. (2009) · Molecular Therapy · doi:10.1038/mt.2008.269 · Cited by 398
NRF2 promotes neuronal survival in neurodegeneration and acute nerve damage
Xiong, W., MacColl Garfinkel, A. E., Li, Y., Benowitz, L. I., & Cepko, C. L. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79735 · Cited by 280
Effective delivery of large genes to the retina by dual AAV vectors
Trapani, I., Colella, P., Sommella, A., Iodice, C., Cesi, G., de Simone, S., Marrocco, E., Rossi, S., Giunti, M., Palfi, A., et al. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201302948 · Cited by 269
Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina
Petrs-Silva, H., Dinculescu, A., Li, Q., Deng, W.-T., Pang, J.-J., Min, S.-H., Chiodo, V., Neeley, A. W., Govindasamy, L., Bennett, A., et al. (2011) · Molecular Therapy · doi:10.1038/mt.2010.234 · Cited by 267
Metadata
- Authors
- Natkunarajah, M., Trittibach, P., McIntosh, J., Duran, Y., Barker, S. E., Smith, A. J., Nathwani, A. C., & Ali, R. R.
- Affiliations
- University College London (GB)
- University of Bern (CH)
- Corresponding author
- Smith, A J
- Venue
- Gene Therapy
- Published
- 2007-11-15
- Volume
- 15
- Issue
- 6
- Pages
- 463-467
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2041995936
- Cited by
- 138
- References
- 38
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 4 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 12 · 2019: 4 · 2018: 7 · 2017: 7 · 2016: 6 · 2015: 13 · 2014: 9 · 2013: 7 · 2012: 5
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- European Commission
- Moorfields Eye Hospital NHS Foundation Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- ocular gene therapy, phototransduction, retinal pigment epithelium, retinal ganglion cells, self-complementary AAV, transduction efficiency, transgene expression kinetics, intravitreal administration, inherited retinal degeneration, murine retina
- MeSH terms
- Dependovirus, Animals, DNA, Single-Stranded, Fundus Oculi, Genetic Vectors, Microscopy, Fluorescence, Pigment Epithelium of Eye, Retinal Degeneration, Retinal Ganglion Cells, Transduction, Genetic, Genetic Therapy, Gene Expression, DNA, Complementary, Transgenes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.